"The Report
Huntingtin (Huntington Disease Protein) - Pipeline Review, H1 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, Huntingtin (Huntington Disease Protein) - Pipeline
Review, H1 2016, provides in depth analysis on Huntingtin
(Huntington Disease Protein)
targeted pipeline therapeutics.
The
report provides comprehensive information on the Huntingtin
(Huntington Disease Protein), targeted therapeutics, complete with
analysis by indications, stage of development, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases. Additionally, the report provides an
overview of key players involved in Huntingtin (Huntington Disease
Protein) targeted therapeutics development and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download Sample copy of this
Report at:
Scope
-
The report provides a snapshot of the global therapeutic landscape
for Huntingtin
(Huntington
Disease Protein)
-
The report reviews Huntingtin (Huntington Disease Protein) targeted
therapeutics under development by companies and universities/research
institutes based on information derived from company and
industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved in Huntingtin (Huntington
Disease Protein) targeted therapeutics and enlists all their major
and minor projects
-
The report assesses Huntingtin (Huntington Disease Protein) targeted
therapeutics based on mechanism of action (MoA), route of
administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news and deals related to Huntingtin
(Huntington Disease Protein) targeted therapeutics
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand the targeted therapy areas and indications
for Huntingtin (Huntington Disease Protein)
-
Identify the use of drugs for target identification and drug
repurposing
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Huntingtin (Huntington Disease Protein) development landscape
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report
Coverage 6
Huntingtin (Huntington Disease
Protein) Overview 7
Therapeutics Development 8
Huntingtin (Huntington Disease
Protein) - Products under Development by Stage of Development 8
Huntingtin (Huntington Disease
Protein) - Products under Development by Therapy Area 9
Huntingtin (Huntington Disease
Protein) - Products under Development by Indication 10
Huntingtin (Huntington Disease
Protein) - Pipeline Products Glance 11
Late Stage Products 11
Early Stage Products 12
Huntingtin (Huntington Disease
Protein) - Products under Development by Companies 13
Huntingtin (Huntington Disease
Protein) - Therapeutics Assessment 15
Assessment by
Monotherapy/Combination Products 15
Assessment by Mechanism of
Action 16
Assessment by Route of
Administration 17
Assessment by Molecule Type 19
Huntingtin (Huntington Disease
Protein) - Companies Involved in Therapeutics Development 21
AFFiRiS AG 21
Ionis Pharmaceuticals, Inc. 22
Neurimmune Holding AG 23
nLife Therapeutics, S.L. 24
reMYND NV 25
Sangamo BioSciences, Inc. 26
UniQure N.V. 27
Voyager Therapeutics, Inc. 28
Vybion, Inc. 29
WAVE Life Sciences Ltd. 30
Huntingtin (Huntington Disease
Protein) - Drug Profiles 31
AMT-130 - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
Antisense Oligonucleotide 1 to
Inhibit Huntingtin Protein for Huntington's Disease - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
Antisense Oligonucleotide 2 to
Inhibit Huntingtin Protein for Huntington's Disease - Drug Profile 33
Product Description 33
Mechanism Of Action 33
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment